title: Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
authors.affiliation: Yatsuo General Hospital, Toyama, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Asahi
authors.forename: Atushi
authors.initials: A
authors.lastname: Mizokami
authors.forename: Yuji
authors.initials: Y
authors.lastname: Maeda
authors.forename: Kazuto
authors.initials: K
authors.lastname: Komatsu
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Koshida
authors.forename: Mikio
authors.initials: M
authors.lastname: Namiki
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000556:secondary*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D004359:Drug Therapy, Combination; D004961:Estramustine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; C071542:cimadronate; D004961:Estramustine; D017430:Prostate-Specific Antigen